Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis

American Journal of Managed Care

Volumn 7, Issue 6, 2001, Pages 609-616

  Ehrich, E W ^a   Bolognese, J A ^a   Watson, D J ^a   Kong, S X ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ROFECOXIB;

ADULT; AGED; ARTICLE; BONE PAIN; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; COXITIS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH SURVEY; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OSTEOARTHRITIS; PARALLEL DESIGN; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LACTONES; MALE; MIDDLE AGED; OSTEOARTHRITIS; PLACEBOS; QUALITY OF LIFE; SULFONES; UNITED STATES;

EID: 0034971996     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Estimates of the prevalence of arthritis and selected musculoskeletal diseases in the United States
2. The MOS 36-item short-form health survey, I: Conceptual framework and item selection
3. Measuring the quality of life of patients with rheumatoid arthritis
4. Methodologic assessment of quality of life measures in clinical trials
5. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model
6. Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans
7. Rofecoxib, a specific inhibitor of cyclooxygenase 2 with clinical efficacy comparable with that of diclofenac sodium: Results of a 1-year, randomized clinical trial in patients with osteoarthritis of the hip and knee
8. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs
9. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis
10. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee
11. Methods for assessing the difference between groups in change when initial measurement is subject to intra-individual variation
12. Effect of specific COX-2 inhibition in osteoarthritis of the knee: A 6 week, double blind, placebo controlled pilot study of rofecoxib
13. Assessing health-related quality of life for clinical decision-making
14. The impact of rheumatoid arthritis and osteoarthritis: The activities of patients with rheumatoid arthritis and osteoarthritis compared to controls
15. The MOS 36-Item Short-Form Health Survey (SF-36), II: Psychometric and clinical tests of validity in measuring physical and mental health constructs